GW researchers receive supplemental grant to measure enhanced immune response of novel adjuvants

2012 MAY 8 -- GW researchers in the School of Medicine, Jeffrey M. Bethony, Ph.D., Associate Professor of Microbiology, Immunology, and Tropical Medicine and David Diemert, M.D., FRCP(C), Associate Research Professor of Microbiology, Immunology, and Tropical Medicine and Director of Clinical Trials for the Sabin Vaccine Institute's Product Development Partnership (PDP), have been awarded a Pilot Grant from the Clinical and Translational Science Institute-Children's National (CTSI-CN) to investigate innovative methods for evaluating the immune response to vaccines with a novel Toll-like Receptor (TLR)-4 agonist adjuvant. The researchers will use several new antibody profiling...

In order to view the entire article, please read your options to the right